BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2333632)

  • 1. [Herpes zoster in cancer patients].
    Bogomolov BP; Bakhur EG
    Ter Arkh; 1990; 62(1):99-103. PubMed ID: 2333632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infection and immunosuppression in cancer patients].
    Kitahara T; Takenaka T; Yoshino M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1108-14. PubMed ID: 2730015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe generalized courses of zoster due to cellular immunologic defects. Importance of an absolute or relative T-cell deficiency].
    Runne U
    Hautarzt; 1978 Mar; 29(3):147-52. PubMed ID: 305913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients.
    Zambelli A; Montagna D; Da Prada GA; Maccario R; Zibera C; Moretta A; Ponchio L; Lozza L; Baiardi P; Maserati R; Marone P; Della Cuna GR
    Anticancer Res; 2002; 22(6B):3701-8. PubMed ID: 12552979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon and herpes zoster.
    Ho M
    N Engl J Med; 1970 Nov; 283(22):1222-3. PubMed ID: 4319628
    [No Abstract]   [Full Text] [Related]  

  • 6. [5-(2-bromovinyl)-2'-deoxyuridine therapy of herpes zoster diseases in patients with malignant primary diseases].
    Wutzler P; Wutke K; Bärwolff D; Reefschläger J
    Z Gesamte Inn Med; 1988 Dec; 43(23):677-80. PubMed ID: 2854331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon, antibody, and other host factors in herpes zoster.
    Stevens DA; Merigan TC
    J Clin Invest; 1972 May; 51(5):1170-8. PubMed ID: 5020430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological view-points on the pathogenesis of zoster].
    Schubert H
    Z Arztl Fortbild (Jena); 1968 May; 62(10):528-32. PubMed ID: 5727607
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical course of herpes zoster in middle-aged and elderly persons].
    Bogomolov BP; Bakhur EG
    Ter Arkh; 1985; 57(5):127-30. PubMed ID: 3875159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Herpes zoster and malignancy].
    Zaha M; Hayashi I; Odashiro M; Mizoguchi H; Fujiwara M; Kato H; Kawamura J
    Masui; 1993 Sep; 42(9):1343-6. PubMed ID: 8230723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic characteristics of the pathogenesis of herpes zoster].
    Seletskaia TA; Shishov AS; Sysoeva KR
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):180-4. PubMed ID: 3872543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic observations on healthy children with a background of herpes zoster].
    Santana R; Ramiŕez A; Ruiz-Maldonado R; Plaza A
    Rev Clin Esp; 1981 Apr; 161(2):99-102. PubMed ID: 6974384
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electron microscopy diagnosis of herpes zoster virus in cancer patients].
    Leite JB; Marques AF; Teixeira MI; Ueda M; Weigl DR; Bianchi A; De Andréa ML; Lopes A; Gomes OM
    Rev Paul Med; 1979; 93(5-6):101-3. PubMed ID: 229536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Herpes zoster observed in malignant tumor patients, with special reference to their etiology and clinical value].
    Sunada T; Tanaka S; Omoto T
    Nihon Rinsho; 1965 Nov; 23(11):2239-45. PubMed ID: 5895395
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the incidence and clinical manifestations of herpes zoster].
    Cerný Z
    Cas Lek Cesk; 1996 Apr; 135(8):244-8. PubMed ID: 8689663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acyclovir and prednisolone on the serological response in herpes zoster.
    Bates CJ; Kudesia G; McKendrick MW
    J Med Virol; 1996 Nov; 50(3):244-8. PubMed ID: 8923289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of the viral attack and cellular rejection reaction in the skin during segmental and exanthematous zoster].
    Orfanos CE; Runne U
    Z Hautkr; 1974 Sep; 49(17):733. PubMed ID: 4440077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.